Global Peripheral Nerve Stimulator Market Size, Share, and COVID-19 Impact Analysis, By Product (Transcutaneous, Percutaneous, and Implantable), By Device Type (Stimulators, CPNB Catheters, Pain Pumps, and Others), By Stimulating Feature (Stimulator Machines with Train of Four (TOF) Monitoring Features and Machines without TOF Features), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Peripheral Nerve Stimulator Market Insights Forecasts to 2035

• The Global Peripheral Nerve Stimulator Market Size Was Estimated at USD 0.62 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.81% from 2025 to 2035
• The Worldwide Peripheral Nerve Stimulator Market Size is Expected to Reach USD 1.04 Billion by 2035
• Asia Pacific is Expected to Grow the Fastest during the forecast period.

The Global Peripheral Nerve Stimulator Market Size was worth around USD 0.62 Billion in 2024 and is Predicted to Grow to around USD 1.04 Billion by 2035 with a Compound Annual Growth Rate (CAGR) of 4.81% from 2025 to 2035. The increasing prevalence of chronic pain nerve injury, PNS technology advancements, and awareness of non-invasive pain management solutions are driving the peripheral nerve stimulator market worldwide.  

Market Overview

The peripheral nerve stimulator market is the industry of healthcare focusing on electrical stimulating devices for treating chronic pain and other neurological conditions. A peripheral nerve stimulator is a medical device that manages chronic pain by stimulating peripheral nerves that transmit pain with electrical impulses. The devices deliver electrical impulses to peripheral nerves, effectively reducing pain signals sent to the brain. The market for peripheral nerve stimulator is primarily driven by the increasing number of patients suffering from nerve injuries, effective technologies in PNS, chronic pain management therapies, and the prevalence of diseases. An increasing demand for improved nerve stimulator outcomes is providing lucrative market growth opportunities by introducing technologically advanced devices. An increasing healthcare infrastructure and healthcare expenditure offer opportunities for manufacturers to expand their customer base.

Report Coverage

This research report categorizes the peripheral nerve stimulator market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the peripheral nerve stimulator market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the peripheral nerve stimulator market.

Driving Factors

The increasing prevalence of nerve-related chronic pain, estimated to affect about 20% global population, which is 1.5 billion individuals, is contributing to driving the market demand for peripheral nerve stimulator. The growing technological advancements, including closed-loop systems, miniaturization, wireless technology, and improved electrode designs for enhancing pain control, improving device comfort, and expanding treatment outcomes, are contributing to propelling the market growth. The growing awareness about the non-invasive pain management solutions, which have several benefits like lower risk of complications, shorter recovery times, less pain & discomfort, and improved quality of life, is driving the market demand for the peripheral nerve stimulator market.

Restraining Factors

The increased cost of devices and preference for drug therapies over neuromodulation are restricting the market growth of the peripheral nerve stimulator. Procedure-related risks, including bleeding, infection, nausea, dizziness, headache, and pain after surgery, may hamper the peripheral nerve stimulator market. Further, regulatory challenges & approval processes, as well as a lack of skilled professionals for handling these devices, are challenging the market.

Market Segmentation

The peripheral nerve stimulator market share is classified into product, device type, and stimulating feature.

• The transcutaneous segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product, the peripheral nerve stimulator market is divided into transcutaneous, percutaneous, and implantable. Among these, the transcutaneous segment dominated the market with the largest market share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The product delivers electrical pulses through the skin to relieve pain by stimulating peripheral nerves and uses low-voltage currents. The non-invasive therapeutics provided by this device for treating arthritis, back & neck pain, fibromyalgia, muscle pain, and neuropathic pain are driving the market in the transcutaneous segment.

• The pain pumps segment dominated the peripheral nerve stimulator market in 2024 and is anticipated to grow at the fastest CAGR during the forecast period.

Based on the device type, the peripheral nerve stimulator market is divided into stimulators, CPNB catheters, pain pumps, and others. Among these, the pain pumps segment dominated the peripheral nerve stimulator market in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. Pain pumps are filled with numbing medicine, which goes through the tube and numbs the nerves that send pain signals from the area of surgery to the brain, blocking the feeling of pain. It is mainly used for multiple sclerosis and cerebral palsy.

• The stimulator machines with train of four (TOF) monitoring features segment accounted for the largest share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period.

Based on the stimulating feature, the peripheral nerve stimulator market is divided into stimulator machines with train of four (TOF) monitoring features and machines without TOF features. Among these, the stimulator machines with train of four (TOF) monitoring features segment accounted for the largest share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. The train-of-four (TOF) monitoring feature is used to assess the neuromuscular transmission when neuromuscular blocking agents (NMBAs) are given to block musculoskeletal activity. They are used in intraoperative and postoperative procedures in orthopaedic surgery for assessing drug delivery. The widespread use of these devices, owing to the increasing cases of arthritis, is driving the market growth.

Regional Segment Analysis of the Peripheral Nerve Stimulator Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the peripheral nerve stimulator market over the predicted timeframe.

North America is anticipated to hold the largest share of the peripheral nerve stimulator market over the predicted timeframe. The growing investments in healthcare infrastructure, along with the increasing awareness about advanced medical solutions, are contributing to driving the regional market growth. Further, the region’s increased prevalence of chronic pain and the rising geriatric population are driving the market demand for peripheral nerve stimulator.  

Asia Pacific is expected to grow at a rapid CAGR in the peripheral nerve stimulator market during the forecast period. An increased patient population, an increasing number of neurovascular diseases, and favourable regulatory policies are contributing to propel the peripheral nerve stimulator market. The region’s increased healthcare expenditure is also responsible for driving the market.

Europe is anticipated to hold a significant share of the peripheral nerve stimulator market during the projected timeframe. Technological advancements, high healthcare expenditure, and a rising number of nerve injury cases are all contributing to driving the market for peripheral nerve stimulator. The robust healthcare system in some countries of the region and emphasis on effective pain management with minimal invasiveness are propelling the market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the peripheral nerve stimulator market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• MEDTRONIC
• Braun SE
• Boston Scientific Corporation
• Curonix LLC
• SPR Therapeutics
• AVNS
• Teleflex Incorporated
• SUNMED
• Xavant Technology (Pty) Ltd
• Vygon
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In January 2025, Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, announced the expansion of MR labeling for its Freedom Peripheral Nerve Stimulator (PNS) System to include full-body 3T MRI scans.
• In January 2024, Nalu Medical Inc., a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, announced the closing of a $65 million equity financing.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the peripheral nerve stimulator market based on the below-mentioned segments: 

Global Peripheral Nerve Stimulator Market, By Product

• Transcutaneous
• Percutaneous
• Implantable

Global Peripheral Nerve Stimulator Market, By Device Type

• Stimulators
• CPNB Catheters
• Pain Pumps
• Others

Global Peripheral Nerve Stimulator Market, By Stimulating Feature

• Stimulator Machines with Train of Four (TOF) Monitoring Features
• Machines without TOF Features

Global Peripheral Nerve Stimulator Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa